In addition, comparisons of the genetic composition of breast cancer CD44+CD24− cells, which are presumed to be “CSCs”, versus CD44−CD24+ cells, which are considered to be “non-stem cells”, have revealed that in some cases these subpopulations are genetically divergent [42,43], which is inconsistent with a model of simple differentiation. This evidence concerns the gene CD44 and breast carcinoma.